Trade Mark Journal No.2026/023 5 June 2026
WO0000001918505 (5)
Office of origin: Denmark
Date of International Registration:10 April 2026
Date of designation in the UK:
10 April 2026

- Class 5
- Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight reduction and long term weight loss maintenance; pharmaceutical preparations for the treatment of liver diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension; pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases; pharmaceutical preparations for the treatment of neurological disorders, including alcohol dependence and alzheimer's disease; pharmaceutical preparations for the treatment of psychiatric disorders, including depression and anxiety.
Novo Nordisk A/S